• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    C

    Christiana Care Health System

    EST. 1888
    2,753论文总数
    6.6万引用总数

    ChristianaCare is a network of private, non-profit hospitals providing health care services to all of the U.S. state of Delaware and portions of seven counties bordering the state in Pennsylvania, Maryland and New Jersey. The system includes two hospitals in Delaware, Wilmington Hospital and Christiana Hospital, and one in Maryland, ChristianaCare Union Hospital in Elkton. ChristianaCare operates the Helen F. Graham Cancer Center & Research Institute, the Center for Heart & Vascular Health, The Center for Women & Children's Health, and ChristianaCare HomeHealth, as well as the Eugene du Pont Preventive Medicine & Rehabilitation Center, and a wide range of outpatient and satellite services. ChristianaCare is headquartered in Wilmington, Delaware..

    论文量&引用量时间轴

    机构学者

    论文(2753)

    年份
    起
    –
    止
    排序
    1Addressing Primary Care Needs in People Living with Sickle Cell Disease : A Narrative Review.
    Amie Patel,Charmaine Wright, Francis Coyne, Rachel J Klein, Max Jordan Nguemeni Tiako, Alice A Kuo,Robert M Cronin

    Adults with sickle cell disease (SCD) are living longer due to advances in care but face a growing burden of chronic comorbid conditions that fall within the scope of primary care. However, primary care providers often lack structured guidance because literature on managing these conditions in the context of SCD is limited. This article outlines clinical approaches to hypertension, diabetes, obesity, chronic constipation, reproductive health, cognitive impairments, depression, and anxiety in people living with SCD. The authors highlight relevant epidemiology, screening recommendations, and treatment considerations that differ from those in the general population. Primary care providers play a crucial role in delivering comprehensive and preventive care to people living with SCD. Specific management of common chronic conditions in this population is necessary to reduce morbidity and improve quality of life.

    2026Annals of internal medicine(2026)引用:1
    引用
    AI阅读
    加入学术空间
    2Extended Follow-up to Compare the PPV, NPV and Clinical Utility of Surveillance Circulating Tumor Tissue Modified Viral (TTMV)-HPV DNA in a Community-Based Head and Neck Cancer Program with Larger Academic Programs
    L. A. Hockstein, S. Shah, A. Katzenberg, S. Park, L. Clements, L. Desouza-Lawrence, J. Amin, A. Raben

    Purpose/Objective(s) TTMV-HPV DNA is an established biomarker for HPV-positive OPSCC. We evaluated both its Positive Predictive value (PPV) and its negative predictive value (NPV) and clinical utility in a community program that uses the assay for pretreatment confirmation and post-treatment surveillance. Materials/Methods Between 2020–2023, 115 OPSCC pts treated with curative intent in a community hospital MDC underwent 659 prospectively collected TTMV-HPV DNA assays (NavDx®, Naveris, Inc.). Baseline HPV status was assessed by p16 immunohistochemistry and, in a subset, confirmed by TTMV-HPV DNA testing (HPV16/18/31/33/35). Post-treatment testing was integrated with imaging and physical examination and performed approximately every 3 months, consistent with NCCN guidelines. Eligible patients completed curative therapy and had ≥1 assay. Surveillance performance was evaluated at the interval level (a period of routine surveillance bounded by treatment or recurrence). Intervals without adequate post-test clinical follow-up (3 months for negative tests and 6 months for positive tests) were excluded. Results The median age of the cohort was 64 years (IQR: 57-68), with 92% of patients (106/115) presenting with nodal involvement at diagnosis. Most patients received CRT (93/115, 81%), either alone (49/115, 43%) or with additional therapy (44/115, 38%). Six patients received extreme de-escalated adjuvant therapy according to the DART protocol (Ma et al., Lancet 2025)(6/115, 5.2%). Median follow-up from end of treatment was 31 months (IQR: 24-37). Pretreatment testing was performed in 77% of patients (89/115), with a median TTMV score amongst positive tests of 337 (IQR: 87-1463). Per-patient pretreatment sensitivity in the p16-positive cohort was 87.5% (70/80, 95% CI: 78–94), consistent with pooled results from academic center studies (sensitivity 87.3%, 95% CI: 79–96). In patients with a positive pretreatment test, 94% achieved resolution of their TTMV-HPV DNA score to zero during or following completion of primary treatment, and only one demonstrated residual disease on imaging or exam. Patients with high nodal burden (N2–N3 disease) were less likely to achieve clearance than those with N0–N1 disease (84% vs. 93%, respectively). During surveillance, 77% of patients (88/115) received one or more follow-up tests (median: 5; range: 1–13). Among 84 evaluable intervals, 77 were all negative with 2 subsequent recurrences, yielding an NPV of 97.4% (95% CI: 91-99.3). 6 pts who initially cleared to zero subsequently tested positive with radiographic evidence of recurrence. One positive patient had an indeterminate PET and subsequently died of CLL, precluding determination of OPSCC recurrence. Conclusion As one of the earliest community-based programs to adopt both pre- and post-tx TTMV-HPV DNA testing for HPV-driven OPSCC, our findings align with larger academic centers and demonstrate a high NPV, supporting the clinical utility of TTMV-HPV DNA in routine community practice.

    2026INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS(2026)
    引用
    AI阅读
    加入学术空间
    3Scholarly Contributions in Complex Benign Gynecology: A Bibliometric Analysis of US Authorship in Focused Literature, 2015-2025
    R Hsu, SLL Kass, KL Karlson, AT Lalla, M Vargas, M Truong

    Study Objective Complex Benign Gynecology (CBG) Fellowship, formerly Minimally Invasive Gynecologic Surgery (MIGS), has expanded substantially over the past decade, yet the scholarly contribution of fellowship-trained physicians and its relationship to the geographic distribution of clinical practice remain uncharacterized. This study examines authorship trends, gender representation and geographic concentration across US-based CBG publications to evaluate the scholarly footprint of structured fellowship education. Design Retrospective bibliometric study. Setting Five major peer-reviewed obstetrics and gynecology journals, 2015-2025. Patients or Participants 1,500 US-origin articles identified via systematic PubMed searches targeting chronic pelvic pain, endometriosis, and uterine fibroids. Non-US articles were excluded. Interventions None. Measurements and Primary Results First and senior author data were extracted and verified using Doximity and publicly available databases. Among fellowship-trained US first authors (n=290), CBG-trained physicians represented 52.8% of first authors and 42.1% of senior authors, the largest fellowship contributor in both positions. CBG senior authorship rose significantly from 22.9% in 2015 to 47.5% in 2025 (Cochran-Armitage Z=4.07, p<0.0001), with year-to-year gains in every interval and the largest single-year increase between 2020 and 2021 (+5.2 pp). Most CBG first authors (77.1%) published within five years of fellowship completion. Female first authorship increased from 57.7% to 75.6% (p=0.0001) and female senior authorship from 29.6% to 61.0% (p=0.0003). When compared to non-fellowship trained authors, CBG senior authorship rose significantly (37.3% to 56.5%; p = 0.001) when analyzed from ten-year span to recent three-year span. Geographically, program-hosting states (n=25 + DC) contributed 93.8% of US CBG publications and 97.3% of CBG-authored papers. Conclusion Structured CBG fellowship training is associated with substantial and growing scholarly contributions, increasing authorship prominence, and rising female representation. Geographic analyses reveal CBG scholarship is highly concentrated within fellowship institutions, paralleling the published clustering of CBG in major academic centers and associated access deficits in non-program regions. This highlights the need for intentional fellowship expansion and research mentorship in underrepresented areas.

    2026Journal of Minimally Invasive Gynecology(2026)
    引用
    AI阅读
    加入学术空间
    4CTNI-36 Mapping the Metabolic Maze: How Whole-Brain Spectroscopic Imaging Redefines Target Volume and Significantly Alters TTFields Dosimetry in Glioblastoma
    Sanjeev Chawla,Archith Rajan, Laiz de Godoy,Sulaiman Sheriff, Kristina Vineis, Demetrius Lee, Fred Miglo,Lisa Desiderio, Atom Sarkar, Rinku Shah,Dawit Aregawi, Tara Morrison,

    Abstract Background Tumor treating fields (TTFields) deliver oscillating electric fields via transducer arrays and is an FDA approved antimitotic therapy for glioblastoma. This study aimed to: (1) utilize whole brain spectroscopic imaging (WBSI)-derived choline/N-acetylaspartate (NAA) maps to define a metabolic target volume (MTV), (2) compare dosimetry profiles between metabolically defined MTVs and conventionally defined anatomically target volumes (ATVs). Methods Ninety glioblastoma patients treated with standard therapy underwent anatomical imaging, and WBSI on 3T-MRI prior to TTFields therapy. The processing steps for WBSI data included field inhomogeneity and eddy current correction, k-space regridding, spatial and Fourier transformation. Quality assurance was assessed using Cramer-Rao lower bounds, line-shape, line-width, CSF contamination, and degree of residual water and lipid signals. Cho/NAA maps, and anatomical images were co-registered and re-sliced. 3D-composite masks were drawn to define ATV covering post-contrast-T1 (PC-T1) and T2-FLAIR abnormalities. A comparable normal-tissue mask was drawn in contralateral normal brain parenchyma by selecting a volume comparable to tumor size and at same slice level. MTV was defined by voxels in tumor region exceeding twice the contralateral mean Cho/NAA value. A comparison was made between MTVs (Cho/NAA abnormalities) and ATVs (PC-T1 and T2-FLAIR). In a pilot sample of 11 patients, finite-element mesh computational modeling (MaxPoint) calculated TTFields power density across 10 regions of interest encompassing both target volumes. Results The Cho/NAA defined MTV (85,422 ± 9,022 voxels) was significantly larger the PC-T1 ATV (36,798 ± 4,301 voxels, p < 0.05), but did not differ significantly from the T2-FLAIR ATV (79,389 ± 9,225 voxels, p = 0.66). While MTV exceeded PC-T1-ATV in all cases, it exceeded T2-FLAIR-ATV in only 69% of cases. MTVs received higher TTFields power-density compared to ATV-T2-FLAIR (3.44 ± 0.69 vs. 2.47 ± 0.25 mW/cm3). Conclusion WBSI derived metabolite maps delineate a more comprehensive representation of tumor’s true spatial extent than conventional MRI and significantly alter dosimetric profiles of TTFields.

    2026Neuro-Oncology(2026)
    引用
    AI阅读
    加入学术空间
    5197 Impact of De-implementing Gowning and Gloving Requirements for COVID-19 on Environmental Waste Creation
    Alexia Foy-Crowder, Rachel Samples,Joseph Kohn, Andrew Jolly, Sangita Dash, Majdi Al-Hasan, Caroline Jozefczyk, Pam Bailey

    Background: In February 2024, Prisma Health, a 17-hospital healthcare system, changed the reflex urine culture criteria to ≥10 white blood cells (WBC) and rejecting cultures if ≥10 epithelial squamous cells in urinalysis (previously included leukocyte esterase and nitrites). In May 2025, we added verbiage to the Epic orderable emphasizing the criteria. Methods: Using the EMR, lists of urinalyses were generated before the reflex criteria change (August 2023, n=229), after (March 2024, n=102), and an additional data pull June/July 2025 to identify patients who had urinalyses done, and to further identify those who had rejected cultures based on the reflex criteria. A subset for pre/post were reviewed, and all patients with rejected cultures were reviewed. Their charts were reviewed and relevant data captured in RedCap databases. Results: Comparing pre-change (n=229) and after (n=102), there was no difference in the two groups for bacteriuria, leukocyte esterase, WBC, nitrites, and epithelial squamous cells (p=0.31). Antimicrobial prescribing was similar between the groups (p=0.17). Out of 24,978 urinalyses with microscopy in June/July 2025, 291 patients had urinalyses that were rejected for cultures (0.012%). Of the 291 patients, 5 were male, 3 nonbinary, and the rest female. Fifty-eight were pregnant persons. Mean body mass index was 32 mg/m2. The top five most common chief complaints were gastrointestinal (n=86), genitourinary (n=46), obstetric (n=41), gynecologic (n=17), musculoskeletal (n=17). For clinician reasoning from note review, most were ordered for suspected urinary tract infection or urinary symptoms (n=134), no rationale documented (n=52), obstetric workup (n=51), metabolic workup (n=16) or sepsis workup (n=16). Ten patients returned to the ED subsequently, but none required additional workup related to their rejected culture. Conclusions: There were no differences between the characteristics of patients between the reflex culture changes. Very few cultures ultimately were rejected due to skin contamination, emphasizing that rejecting samples for culture is a viable option to improve diagnostic stewardship. The predominance of female and obese patients with contaminated urinalyses emphasizes additional attention to urine collection techniques. Fifty eight obstetric patients were ordered routine urinalyses, not following the orderset obstetric patients excluded from reflex culturing; providers need to be educated to ensure they follow pathways in place. Improved documentation about symptoms and different uses for urinalysis is is key for interpretation of this test.

    2026Antimicrobial Stewardship & Healthcare Epidemiology(2026)
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2753 篇论文

    合作机构(100)

    德拉华大学合作论文 118
    杜克大学合作论文 92
    托马斯杰斐逊大学合作论文 90
    哥伦比亚大学合作论文 81
    埃默里大学合作论文 79
    华盛顿大学合作论文 65
    宾夕法尼亚大学合作论文 62
    匹兹堡大学合作论文 56
    阿拉巴马大学伯明翰分校合作论文 53
    cedars-sinai 医疗中心合作论文 52

    机构统计